Sign In
NewsRadar

Evolva SA

Evolva is creating, developing and manufacturing small molecule pharmaceuticals and related compounds using evolutionary technlogies

• Show past press releases
• Edit this company

Elevator Pitch
Evolva unlocks the main productivity and process constraints of the pharmaceutical industry. Our approach allows us to provide unique, sophisticated, highly functional molecules to the pharmaceutical and chemical/nutritional industries.

Contact Information
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 
Hagmattstrasse 6
Allschwil
Basel 4123
Switzerland
+41 (0)61 485 2000
+41 (0)61 485 2001
http://www.evolva.com
Neil Goldsmith
+41 (0)61 485 2000

Company Facts
Founded:Apr 2001
Founders:Neil Goldsmith, Alexandra Santana Sorensen, Soren Nielsen
CEO:Neil Goldsmith
CTO or technical lead:Jutta Heim
CFO or finance director:Jakob D.Hansen
Head of Sales:
Head of Marketing:

Stage:Public
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:Yes
Seeking Partnerships:Yes

Non-executive Board Members

  • Jean-Philippe Tripet, Managing Partner , Venture Associates
  • Trine Winterø, Senior Investment Manager, Dansk Erhvervsinvestering
  • Stefan Buhler, Partner, Rohner Rechtsanwälte
  • Steen Helde Hemmingsen, Senior Investment Manager, Dansk Innovationsinvestering

    Key Customers

    Key Business Partners

  • TopoTarget
  • BioLigands
  • Dako Cytomation
  • University of Southern Denmark
  • University of Frankfurt
  • Hebrew Univ. of Jerusalem

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    26,126
    Tech investments
    From our Online Data Service
    16,881
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Sep 13N/AEnergy related
    Sep 13€12.6MConsumer electronics
    Sep 12€39.0MBiopharmaceuticals
    Sep 12€2.3MInternet commerce
    Sep 12€2.1MInternet services
    Sep 12€4.0MMedical devices
    Sep 12€9.0MSoftware development

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.